Definitive Contract HHSD200201792736C
Award Date 12/23/16
Potential Completion Date 2/28/18
Potential Value $541M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $83,765,821.70 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. for the provision of 2016 adult influenza vaccines. The contract is a firm fixed-price award without any set-aside designation, with a period of performance ending on February 28, 2017. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of pharmaceuticals and medical supplies, and has provided a range of vaccine products and services to federal agencies...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit organization that manufactures vaccines and pharmaceutical products. The contract, valued at $330,149,915.00, is for the delivery of 2016 seasonal and pre-pandemic influenza vaccines to support the CDC's public health preparedness and disease prevention efforts. The contract was awarded on a firm fixed-price basis without any set-aside designation, and...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of pharmaceutical goods. The $28.3 billion firm fixed price contract is for the provision of pediatric vaccines under the Vaccines for Children (VFC) program. The contract has no set-aside designation and runs through March 31, 2010. Sanofi Pasteur operates a facility in Swiftwater, Pennsylvania to fulfill the...
- This is a federal contract award to Sanofi Pasteur Inc., a pharmaceutical company, by the Centers for Disease Control and Prevention (CDC) to provide adult influenza vaccines. The contract is a definitive contract with a firm fixed price of $81,449,899.60 and an ultimate completion date of February 28, 2018. There is no set-aside designation for this award. Sanofi Pasteur Inc. is the prime contractor and has provided a range of vaccine products and services to various federal agencies, including...
- This is a $36,045,700.00 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide vaccines for adults. The contract has an ultimate completion date of June 30, 2016 and was awarded on July 1, 2015. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer of goods that provides a range of vaccine products and services to various federal agencies. The contract is not a set-aside award. In addition to this contract, Sanofi...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a definitive, firm fixed price contract to Sanofi Pasteur Inc. for the delivery of adult influenza vaccines. The contract has a potential value of $81,449,899.60 and a completion date of February 28, 2019. The place of performance is Atlanta, Georgia. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, medical supplies, and related services to U.S....
- This is a $35,673,100.00 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer of goods. The contract is for the provision of vaccines, pharmaceuticals, medical supplies, and related services, with performance to occur at Sanofi Pasteur's Swiftwater, Pennsylvania facility or other designated locations. The contract is not associated with a set-aside designation. Sanofi Pasteur Inc. holds several...
- This is a delivery order awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by a U.S. government agency. The $1,428,430.40 firm fixed-price contract is for the delivery of influenza virus vaccines. The performance period is from the award date of July 3, 2025 through the ultimate completion date of September 26, 2025. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various federal agencies, including the Centers for Disease...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the production of influenza virus vaccines. The contract, awarded by the Medical Supply Chain division of the Defense agency, is a delivery order with a firm fixed price of $3,150,107.50 and an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines and medical countermeasures to various...
- This is a $87,130.68 firm fixed price purchase order awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc. for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 29, 2021 and does not have a set-aside designation. Sanofi Pasteur Inc. is a foreign-owned, for-profit manufacturer that provides vaccines, pharmaceuticals, and medical supplies to federal agencies. The company holds several indefinite delivery vehicles (IDVs) with agencies...